Amgen still needs to show that the reduction in Lp(a) is accompanied by lower rates of cardiovascular outcomes, and will endeavour to show that in its phase 3 programme which will start to enrol a ...

Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial ...

You can check if your tech qualifies here. Having risen in early trading this morning, the oil price has now fallen back by more than 3.5% today. A barrel of Brent crude will now set you back just ...

Abstract: Existing firing schemes for the firing of three-phase SCR bridge rectifiers used for industrial applications employ equidistant firing pulses. Mostly they consist of six identical phase ...